The Pristina Duo is built on the proven Senographe Pristina platform and has been specifically developed to expand breast cancer screening programs, close gaps in care, and provide more women with access to early detection. Pristina Duo prioritizes patient comfort and enhances the examination experience while also simplifying the daily workflow for radiographers and radiologists. The system…
Mammo-14 for quality assurance / constancy test at digital mammography systems according to DIN 6868-14.Also Available: Mammo-162 for quality assurance / acceptance test at digital mammography systems according to DIN 6868-162. For Quality Assurance at Tomosynthesis mammographic systems, upgrade kits are also available.
The mamTOMO phantom is a novel approach in DBT QA. The phantom incorporates 3D test objects that simulate lesions and nonspiculated masses in a nonhomogeneous background.An associated automated evaluation software assists at all test stages from image processing, statistic data evaluation to extrapolation of threshold diameters for lesion perceptibility.
Premium digital remote controlled system for full clinical coverage in R/F applications New tomosynthesis function New borderless tabletop and touch screen collimator New touch screen control console with integrated intercom system and smart-touch joysticks Simplified patient positioning system through integrated camera Availablable with DSA and stitching…
Compact and cost-effective digital system for all the needs of radiographic and R/F imaging, new tomosynthesis functionTouch screen collimator, new touch screen control console with integrated intercom system and smart-touch joysticksSimplified patient positioning system through integrated cameraAvailable with DSA and stitching options, Detector size: 43 × 43 cm
Premium digital remote controlled system with OPEN tabletop, allowing 4-side access to the patientNew tomosynthesis functionTouch screen collimatorNew touch screen control console with integrated intercom system and smart-touch joysticksSimplified patient positioning system through integrated cameraAvailable with DSA and stitching optionsDetector size: 43 × 43 cm
Tomosynthesis function with selection of three scan angles: 15°, 24° and 50°Available with Amorphous Selenium FPD (standard or fast speed for tomo scan)Special anti-scatter grid for tomoDynamic collimator with automatic recognition of compressor paddleDual AEC: PRE in function of effective Breast Density and FAST in function of compressed breast thicknessFull DICOM Acquisition…
+90° and -90° tiltingUnmatched variable height from 38 to 148 cmUnmatched patient coveragePatient weight up to 310 kgAutopositioning regarding each protocolMotorized: Automatic positioning, collimation, filtration, parametersSmart access for secure patient transferIntuitive user interfaceWireless IR remoteSecondary consoleDSAStitchingTomosynthesisDose optimization with virtual…
Unmatched patient coveragePatient weight up to 310 kgAutopositioning regarding each protocolSmart access for secure patient transferDose optimization with virtual collimation, additional filtration, video camera ...Intuitive user interfaceWireless IR remoteSecondary consoleDSAStitchingTomosynthesisSecond tubestand and additional detectorsMotorized: Automatic positioning, collimation, filtration,…
Unmatched patient coveragePatient weight up to 310 kgAutopositioning regarding each protocolSmart access for secure patient transferDose optimization with virtual collimation, additional filtration, video camera ...Intuitive user interfaceWireless remoteSecondary consoleDSA / stitching / tomosynthesisSecond tubestand and additional detectorsMotorized: Automatic positioning, collimation,…
+90° and -90° tiltingUnmatched variable height from 38 to 148 cmUnmatched patient coveragePatient weight up to 310 kgAutopositioning regarding each protocolMotorized: Automatic positioning, collimation, filtration, parametersSmart access for secure patient transferIntuitive user interfaceWireless IR remoteSecondary consoleDSA / stitching / tomosynthesisDose optimization with virtual…
Digital mammography system for conventional 2D imaging, diagnostic imaging, stereotactic biopsies and Digital Breast Tomosynthesis (DBT)Intelligent Planmed Clarity Flow dual touch screen user interface that adapts to different imaging modesImage post processing that can be tailored to radiologist preferencesIntegrated MaxView breast positioning system for maximal tissue visibilityModular…
Four-way floating tabletop with a rear accessibility - Minimum table to floor distance for a safer patient access - Autofocusing Grid for a wide range of focal distances - Software algorithms (Virtual Grid and Virtual Scan) for high image quality and low dose - Tomosynthesis, Dual Energy, Stitching and DSA for specialized examinations - Fast and efficient workflow in a single integrated imaging…
Improved product range for the renowned Planmed Clarity family3x faster next generation digital breast tomosynthesis (DBT)Planmed contrast-enhanced mammography (CEM) High-precision diagnostics with Planmed GuidedBiopsy
Giotto Class is an advanced breast tomosynthesis (DBT) system.It features a unique, particularly ergonomic design which ensures patient comfort and easiness for the operator. The C-Arm stand enables a wide freedom of inclination: it can be tilted down- and up-wards to maximize patient comfort and breast positioningThe gantry is designer for biopsy in prone position too
Excellent patient accessibility thanks to the low distance from the floor - Touch screen display on the collimator for the control of the movements of the table -High weight capacity for examinations for obese patients - Motorized dual grid system for the automatic selection of the most appropriate grid - Dose reduction, intuitive gesture and post-processing functions to improve diagnostic exams…
iotto Class S is a versatile system that can be be configured for 2D or/ and 3D breast tomosynthesis imaging choosing between different options, accessories and advanced interventional applications like high-precision tomo-guided biopsy or CEM, including an integrated biopsy specimen checker . It features a unique, particularly ergonomic design which ensures patient comfort and user-friendliness…
Artificial intelligence is reshaping how clinicians identify women at higher risk of breast cancer – and may soon guide decisions on supplemental screening and treatment. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting in Aberdeen, Scotland, two experts presented their latest findings on AI-driven risk stratification and response prediction.
Breast imaging for male and transgender patients remains an under-researched field with significant gaps in guidelines and clinical practice. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting, experts presented findings from a pan-European survey on male breast imaging and announced plans for a similar initiative focusing on transgender patients.
Minimally invasive surgical interventions, innovative imaging and the use of AI: At the upcoming EUSOBI congress in Lisbon, experts present and discuss the latest advances in breast imaging. We spoke with Tanja Brycker from Hologic ahead of the event about new trends in women’s health, the company’s investment in innovation and education, and what the future of mammography looks like with the…
Evidence of the superiority of tomosynthesis for breast cancer detection is stacking up, with new results from a 10-year study further demonstrating the 3D imaging technique's benefits.
Although the Covid-19 pandemic is behind us, healthcare facilities continue to experience workflow challenges and resource constraints impacting women’s health and a patient’s ability to receive a timely diagnosis. Clinical specialties like breast radiology and cytology are especially susceptible to these issues and continue to experience backlogs, which impact their ability to deliver timely…
The IRCCS in Bologna has inaugurated a state-of-the-art integrated PET/CT system. This cutting-edge technology allows for the entire human body to be studied in a single scan, even detecting the smallest tumour cells.
Current AI systems for detecting breast cancer from mammography exams are more likely to produce false-positive results in black women and older patients, a new study finds.
A clinical trial has revealed the effectiveness of '3D mammography' in reducing by almost half the incidence of interval breast cancer appearing between two rounds of screening.
Awareness of the importance of women’s health is on the rise, but many challenges remain: At ECR 2024 in Vienna, we spoke with Hologic about their continued evaluation of healthcare efforts for women. At the congress, the company also shared how AI could be used to mitigate the effects of medical staff shortage.
While having more centers adopt digital breast tomosynthesis (DBT) for breast cancer screenings into their practice is a positive change, it also presents some challenges for radiologists—particularly the increased number of images for radiologists to review. This challenge has paved the way for AI to offer innovative workflow solutions for radiologists that do not sacrifice accuracy.
At the EUSOBI congress in Valencia, Hologic showcases its women's health portfolio, announces global partnerships for breast health - and even brings a sweet treat for the congressgoers.
A new mammography system was introduced at the EUSOBI 2023 congress by Siemens Healthineers. The system, which uses wide-angle tomosynthesis, was presented as "groundbeaking" by the company.
With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for breast cancer, and in the recommendations the Council formally recognized the advantages of digital breast tomosynthesis (DBT). This landmark acknowledges the research on and benefits of DBT, advocating…
Mammography has been an essential imaging technology for breast cancer detection for decades. As the industry has continued to innovate, one advancement in mammography has particularly changed the landscape of breast imaging: digital breast tomosynthesis (DBT), also known as 3D mammography.
Ultrasound is an effective standalone diagnostic method in patients with focal breast complaints, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). Focal breast complaints can refer to pain, lumps, nipple discharge or other symptoms and conditions confined to a specific area of the breast.
In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone.
Compared to other common supplemental screening methods, breast MRI was superior at detecting breast cancer in women with dense breasts, according to a new study.
The need for breast cancer screening of transgender individuals has been a topic of uncertainty until recently, due to lack of reliable patient data, consensus by radiologists, published research, and recommended guidelines. A 2021 survey of Society of Breast Imaging (SBI) members revealed that ‘breast radiologists differ in their practice and knowledge regarding screening of transgender…
Patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis may benefit from biopsy of all areas, given the variation of pathologic diagnoses across individuals.
Contrast-enhanced mammography (CEM) has gone a long way since it was first approved by the Food and Drug Administration (FDA) in 2011. An Italian expert explained how useful the modality has become in breast imaging in a dedicated course at ECR 2022.
“With Your Stories – lifetime healthcare support” is the future-driven approach to benefit patients through even better prevention, diagnosis, treatment and follow-up and thus help them in the pursuit of a healthy life.
Groundbreaking technologies have improved our ability to accurately diagnose breast cancer and reduce callbacks, focusing on compassionate care for patients as they move along their breast health journey.
The breast imaging field plays a critical role in women’s health and wellbeing around the globe. Bringing together experts, leaders and innovators from across the breast imaging landscape, the 2021 European Society of Breast Imaging (EUSOBI) Congress comes at a crucial time and represents a pivotal opportunity for the industry as a whole. Taking place online from 4-28 October, 2021, the virtual…
The Covid-19 pandemic continues to impact people’s health across the world. This goes beyond the disease itself, as healthcare systems adapt how they provide services. Routine screening has been severely affected with screening programmes reduced or paused.
The contribution of Artificial intelligence (AI) has great potential in breast imaging efficiency, Professor Linda Moy MD told attendees at the 2021 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium this April. AI models for breast imaging have focused mainly on the diagnostic classification and detection of breast cancer.
The pandemic has presented healthcare systems with new challenges, resulting in backlogs of routine screenings and delayed procedures which threaten the health and wellbeing of patients, as well as the ability of facilities to serve their communities. In order to address these widespread issues, we need to ensure that healthcare professionals are able to operate with precision, confidence and…
Medical technology company iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval breast cancer, according to a new retrospective analysis. The aim of the study was to determine if adding AI to reading mammography as a supportive tool may help in decreasing the interval cancer rate in population-based organized mammography screening programs in Germany.
The impact of Covid-19 has been devastating; countless lives lost, millions of infections worldwide, health systems overwhelmed and economies rapidly shrinking. Screening, such as for breast or cervical cancer, is an area particularly affected, with numerous appointments delayed.
Digital breast tomosynthesis (DBT) increases detection of breast cancer in symptomatic women under the age of 60, especially in dense breasts. A large, multi-institutional study conducted in the United Kingdom comparing the sensitivity of full-field digital mammography (FFDM), DBT, and FFDM plus DBT supports findings of two similar published studies, both conducted in China in the same time frame.
In clinical practice, planar X-ray images are usually the first imaging technique used. In musculoskeletal imaging, this can be a shoulder in AP and lateral projection. In many of these cases, the 2D technique is not sufficiently informative and further clarification is required, which means additional waiting times or completely new appointments. The DTS allows the diagnostic cycle to be…
Hologic, Inc. announced the commercial availability in Europe of its 3DQuorum Imaging Technology, Powered by Genius AI. The innovation was designed to help improve mammography efficiency and workflow, which is critical as clinics strive to manage the backlog of women whose routine breast screening was delayed due to the COVID-19 lockdown.
Is mammography still the best method for breast cancer screening? For a number of breast cancers, the latest scientific findings suggest otherwise. For more than a decade, Professor Christiane Kuhl MD, Director of the Clinic for Diagnostic and Interventional Radiology at the University Hospital RWTH Aachen, has researched the use of MRI in breast cancer screening.
40 years ago, anticipating the huge impact of computers in radiology, a group of visionaries formed the Radiology Information System Consortium (RISC). In 1989, RISC created the Society for Computer Applications (SCAR) to promote computer applications in digital imaging. Those organisations became the Society for Imaging Informatics in Medicine (SIIM). At SIIM 2020, a virtual meeting, experts…
Agfa announces the launch of its digital tomosynthesis solution, which offers a fast, economical and low-dose technique to separate anatomical overlap in a variety of applications. Powered by Musica, digital tomosynthesis automatically delivers 3D reconstructions with optimal contrast and consistent quality across slices and images. The digital tomosynthesis solution can add clinical value in a…
Carestream’s Digital Tomosynthesis (DT) functionality—a three-dimensional extension of general radiography—has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Simplifying workflow and reducing exam time, DT technology is an upgradable option on the Carestream DRX-Evolution Plus System, a versatile digital radiography system that can perform a wide range of…
Although breast cancer (BC) mammography screening enables early detection of breast cancer, mammography presents issues such as variability between the radiology readings and shortage of radiologists. This area of medical imaging is where artificial intelligence (AI) could help make the biggest difference and improve patient outcome.
Carestream will introduce a three-dimensional extension of general radiography through its Digital Tomosynthesis (DT) functionality (Pending FDA 510(k) clearance) at this year’s Radiological Society of North America conference in booth #7513, North Hall. Simplifying workflow and reducing exam time, Carestream’s DT technology is an upgradable option on the DRX-Evolution Plus System. This DT…
The professionals we all rely on to keep us healthy, they rely on X-Ray imaging systems empowered by flat panel detectors and software solutions provided by Thales. Our solutions offer superior accuracy and advanced image processing to help image interpretation while decreasing radiation exposure. They also include a variety of innovative features that simplify the daily workflow of healthcare…
Fujifilm is a pioneer in digital radiography technology since the early 1980s: since then we have continuously been developing innovative technologies, creating products that deliver greater benefits and improved care to both customers and patients. In the breast screening segment, Fujifilm's strong commitment to continuous technology evolution and a clear commitment in providing innovative…
Pete Valenti, Hologic’s division president of breast and skeletal health solutions, talks about how AI is driving innovation in breast health technology. Underpinning that evolution more recently has been the acquisition of two organisations – digital specimen radiography specialists Faxitron Bioptics and BioZorb marker manufacturer Focal Therapeutics.
After screening 15 000 women over a period of five years, a major clinical study in Sweden has shown that 3D mammography, or breast tomosynthesis, detects over 30% more cancers compared to traditional mammography – with a majority of the detected tumours proving to be invasive cancers.
Tomosynthesis is under international review, with a surprising number of enticing studies carried out in Northern European countries, among them one headed by Professor Sophia Zackrisson at Lund University, Sweden. In our interview, she not only revealed surprising trial results, but also shared her thoughts on practical implementation and unusual speed-reading methods. ‘Our institute’s…
The UNESCO World Heritage City Bergen is seen as the gateway to the fiords of Norway. However, for radiologists the city offers an even more interesting attraction than Scandinavian landscapes. Bergen features one of the largest randomised control trials to compare digital breast tomosynthesis (DBT) with digital mammography (DM): the To-Be trial. Professor Solveig Hofvind, head of BreastScreen…
Artificial Intelligence (AI) and machine learning are poised to transform healthcare, potentially freeing practitioners across many disciplines from routine tasks and saving lives through efficient early detection. Offering insight into the health of both individuals and populations, these ’deep learning‘ algorithms have the potential to process vast amounts of data and identify warning…
Original Equipment Manufacturers (OEM) and end-users in the field of dynamic radiology can now benefit from new detectors and imaging solutions to further enhance patients’ examinations. The digital technologies produce greater quality images at a lower dose for end-users and patients, which helps OEMs to make their systems more attractive on the market. Thales is driving the shift from…
Tracy Accardi, Hologic’s Vice President (Global R&D), spoke of the importance of innovation, tomosynthesis, artificial intelligence/deep learning and open dialogue with the radiology community. Hologic addresses a broad spectrum of gynaecological, perinatal, aesthetic, skeletal and breast women’s health issues. To enhance this approach, Accardi, explained the importance of working closely…
Royal Philips, a global leader in health technology, and Hologic, Inc., an innovative women’s health company, announced a global partnership agreement to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics and services for screening, diagnosis and treatment of women across the world. The collaboration combines Hologic’s innovative…
“With Your Stories – lifetime healthcare support” is the future-driven approach combining the best of two worlds by using our insight and expertise in medical imaging systems and laboratory instrumentation to benefit patients through even better prevention, diagnosis, treatment and follow-up and thus help them in the pursuit of a healthy life.
What beats digital mammography to detect breast cancer in asymptomatic women? Digital breast tomosynthesis (DBT) – was a big discussion at RSNA 2017. Sarah M Friedewald MD, medical director of the Lynn Sage Comprehensive Breast Center of Northwestern Memorial Hospital in Chicago and its division chief of breast and women’s imaging, discussed the clinical implications of DBT for routine…
Over the last 60 years, medicine has made major advances in diagnosis, treatment and surgery. Radiography and Fluoroscopy imaging are essential to medical science. As a result, Original Equipment Manufacturers (OEM’s) need to deliver ever more sophisticated turnkey platforms for their systems which are dedicated to end-users. Thales has designed a platform that meets all of these needs. ArtPix…
A controversy regarding the benefit of early screening programmes for breast cancer continues. Germany, Austria and Switzerland have developed individual strategies. European Hospital asked three experts from these countries to outline each chosen system. Markus Hahn MD, senior consultant at the University Breast Centre in Tübingen, Martin Daniaux, MD, Head of Breast Diagnostics at the Breast…
Breast diagnostics are undergoing considerable change, with new technology facilitating alternative procedures. Genetics and nuclear medicine also enhance diagnostic possibilities. During our EH interview, Professor Rüdiger Schulz-Wendtland described current changes in breast diagnostics. ‘To date, complementary breast diagnostics has comprised clinical, sonographic and mammographic…
‘Clinicians across Europe have made clear their desire for breast cancer screening technology that offers improved accuracy, clarity and workflow, and the 3Dimensions system addresses each of those specific areas,’ Hologic’s Jan Verstreken, Regional President for EMEA and Canada, pointed out during the launch of the new system. This is the latest in the firm’s breast cancer screening,…
Despite rigorous quality assurance of breast cancer screening programs, ‘both, over- and under-diagnosis of breast cancer is a challenge,’ says leading radiologist Christiane K Kuhl, from the Department of Diagnostic and Interventional Radiology, at the University of Aachen, Germany. ‘Mammography is a good screening test – but has its limitations especially, but not only, in women with…
Shimadzu, a worldwide leading manufacturer of diagnostic imaging equipment, achieved the ‘Global General Radiography Product Line Strategy Leadership Award 2017’.
Siemens Healthineers employees Dr. Klaus Engel and Dr. Robert Schneider have been nominated for the German Future Prize along with Professor Franz Fellner, MD, for the development of the visualization technology Cinematic Rendering.
Hologic, Inc. announced that the 3Dimensions mammography system, the fastest, highest resolution breast tomosynthesis system ever, is available for purchase in Europe. The new product is the latest addition to Hologic's portfolio of market-leading breast cancer screening, diagnostic and interventional solutions. It offers a variety of groundbreaking features designed to provide higher quality 3D…
A physician has basically two possibilities to look inside a body: putting a scalpel to the patient’s skin or using an imaging device. Both options have advantages and disadvantages.
The European Society of Breast Imaging (ESOBI) promotes high quality breast imaging across Europe by developing education and training, encouraging research and promoting guidelines and standards. This year’s meeting (23-24 September) was held in collaboration with the French Society La Société d’Imagerie de la Femme (SIFEM) and drew around 600 radiologists. The event included a two-day…
Dr Massimo Calabrese, head of the Complex Operative Unit of Diagnostic Senology in Genoa’s San Martino Hospital, examines aspects of stereotactic breast biopsy procedures and workflow and the need for improvements in certain areas of breast diagnostics.
The new Sofia 3-D breast ultrasound system solves all the economic and logistic challenges associated with whole-breast ultrasound by using a full-field radial scanning method, the firm reports. The resulting throughput, efficiency, and patient comfort make Sofia an ideal solution for women with dense breasts.
Italian-led research has highlighted the value of utilising additional screening technologies to help diagnose breast cancer in some women. Interim analysis from the Adjunct Screening with Tomosynthesis or Ultrasound in Women with Mammography-Negative Dense Breasts (ASTOUND) study has delivered evidence of the potential benefit of adding either ultrasound or tomosynthesis to standard mammograms…
Breast tomosynthesis imaging, Hologic calls it 3-D mammography, is proving to be the best modality to image breast cancer. ‘The Hologic tomosynthesis system has demonstrated superior clinical performance to conventional 2-D mammography in a number of metrics, in particular showing improved detection of invasive cancers and reductions in recall rate,’ the manufacturer reports, adding: ‘Now…
Tomosynthesis is a breast cancer screening and diagnostic modality that acquires images of a breast at multiple angles during a short scan. The individual images are then reconstructed into a series of thin, high-resolution slices typically one mm thick.
As a leading global provider of both diagnostic imaging and analytical instrumentation technologies, Shimadzu offers broad expertise in medical imaging and mass spectrometry detection platforms helping to deliver a measurable impact on healthcare and diagnosis. The company is the perfect partner for transformational technologies to accelerate diagnosis.
Using an iodinated contrast agent, I-View software on the Hologic tomosynthesis system enables the user to image the functional 2-D contrast uptake and the morphological mammography images in rapid sequence and combine these three image sets into a single co-registered study.
Tomosynthesis is an advanced application that allows a multi-slice acquisition and provides a reconstruction of a volume. Several acquisitions at low dose are acquired with a single sweep of the X-Ray tube around the region of interest.
Results from recent trials are promising: an almost 40% increased breast cancer detection rate from digital breast tomosynthesis (DBT) screening compared to conventional mammography.
In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women. However, the research showed increased risk for women with large breasts or breast implants, who must often receive extra screening views, increasing their radiation exposure.
A magnetic resonance (MR) breast imaging technique that uses no ionizing radiation or contrast agent could reduce unnecessary biopsies by providing additional information about suspicious findings on X-ray screening mammography, according to a new study published online in the journal Radiology.
The vast amounts of data accumulating in breast diagnostics require new methods to extract clinical information in a practical way. When dealing with large amounts of data that is too big or too complex to be analysed with traditional data processing applications, the talk today is of ‘Big Data’. The data volume accumulating in breast diagnostics has become increasingly complex over recent…
Shimadzu, worldwide leading manufacturer of diagnostic imaging equipment, has released the new digital radiography system RADspeed Pro EDGE in 2015 – the year of Shimadzu’s 140th anniversary. The system provides a wide range of functionalities: from tomosynthesis via dual-energy subtraction to modern auto-stitching to support diagnostics in clinical applications.
MRI is increasingly relevant to cancer management, especially to detect breast carcinoma. Professor Christiane K Kuhl from the department of diagnostic and interventional radiology at the University of Aachen, Germany, strongly advocated in favour of MRI in breast cancer screening during a dedicated Satellite Symposium organised by Bracco at ECR 2015. Report: Mélisande Rouger
The son of a craftsman making Buddhist altars, he was driven to create instruments for physics and chemistry. Attending the Physics and Chemistry Research Institute he gained experience with a variety of technologies and fields of expertise. He was convinced that Japan, as a should work towards becoming a leader in science. At the dawn of the industrial revolution and scientific age in 1875 he…
At the recent North American IHE Connectathon in Cleveland, Sectra (STO: SECT B) successfully completed testing of the IHE profiles MAMMO and DBT (Digital Breast Tomosynthesis). The testing was done using Sectra PACS which implements the Image Display and Image Manager actors of these profiles.
Premieres in Europe: The new RADspeed fit (DR ready) with its best-in-class features for general radiography as well as the new MobileDaRt Evolution EFX for mobile X-ray applications are the most recent developments provided by Shimadzu. Together with angiographic, R/F and C-arm systems, they make the main attractions on Shimadzu’s stand at ECR 2015 in Vienna, Austria – 4-8 March, Expo C,…
Carestream will show enhancements to its digital breast tomosynthesis (DBT) module including a slabbing tool, improved workflow capabilities and the display of DICOM-compliant 2D synthetic views (which are generated from the 3D dataset) at the 2015 European Conference of Radiology. The latest DBT module is currently available.
Carestream scientist Dr Samuel Richard will present a scientific paper documenting the impact of advanced imaging technologies on lung nodule conspicuity at the 2015 European Congress of Radiology (ECR).
Created by the Dutch industrialist family Hilekes, in 1993 Medicor expanded beyond the Benelux countries to enter the German-speaking world as Medicor Germany GmbH, selling contrast media injectors for CT, MRI and angiography.
Digital breast tomosynthesis offers a number of benefits over other modalities but challenges remain in its optimum clinical application.
Screening for lung cancer saves lives. This fact has been documented by outcomes of the U.S. National Lung Screening Trial (NLST) which showed a 20% reduction in lung cancer-specific deaths in patients who had a chest CT screening. What is controversial is how to establish the radiology resources needed to perform exams for all the people who need it and then how to pay for the exams.
Why is early detection of breast cancer so important? Professor Dr Walter Heindel, Director of the Institute of Clinical Radiology at University Hospital Münster, Germany, offers an unequivocal answer.
In May, 2013, the U.S. Food and Drug Administration (FDA) finally took the training wheels off tomosynthesis by approving the use of Hologic's new C-View 2D imaging in place of conventional 2D mammograms previously required as part of a breast tomosynthesis screening exam.
RSNA opens a window for one week where companies can showcase the latest technologies ahead of regulatory approval. Fujifilm seized this opportunity to introduce the leading edge in tomosynthesis, the Amulet Innovality that it has launched in Europe, and that once given the green light by the FDA will come to America under the name Aspire Cristalle.
Dr Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
Dr. Paula Martínez Miravete didn’t set out to change breast imaging in Spain when she first adopted breast tomosynthesis.
New business ventures, new systems – and those include 3-D mammography
With 350,000 mammography screenings annually, Unilabs Sweden finds itself on the leading edge for research in mammography and pioneering patient education programmes. John Brosky reports
Carestream will demonstrate top of the edge technologie and launches digital breast tomosynthesis module for its Vue Mammo Workstation on booth 2636 in Chicago.
Much, if not even everything, may have been said already about the multimodal approach in breast diagnostics. However, Professor Rüdiger Schulz-Wendtland at the Institute of Radiology, University Hospital Erlangen, says there is still surprising news from this field – innovations in multimodal breast diagnostics, for example.
Magnetic resonance imaging is a long-established, highquality and safe examination tool. Why, therefore, do German gynaecologists and radiologists question its value in breast cancer diagnoses? Indeed the question ‘Breast MRI - yes or no?’ has split the medical community. One ardent champion of breast MRI is Professor Christiane Kuhl MD, director of the diagnostic and interventional radiology…
A multi-disciplinary team approach is crucial if healthcare professionals are to offer breast cancer patients the best possible care in the years ahead. That was the opinion voiced by three experts at an ECR 2012 session on Saturday afternoon with delegates addressed by a radiologist, surgeon and an oncologist.
Hologic a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will launch four ready-to-market technologies at the European Congress of Radiology.
MRI: Although an area of constant debate, this is becoming a widely accepted clinical modality in Europe. However, researchers in The Netherlands have shown that performing pre-operative breast MRI in all women with invasive lobular carcinoma (ILC) can reduce the need for re-excision.
Radiology constantly evolves. There are technical advances in terms of the capabilities of various modalities, greater clarity from contrast agents that are also safer for patients, and innovation in techniques that gains even greater performance from existing equipment, or enables further development.
In Europe, 350,000 women are diagnosed with breast cancer annually. About 90% of them can be cured if the cancer is detected at a very early stage. To improve early detection almost all European countries have gradually initiated regional screening programmes, even though the benefits are discussed controversially from time to time.
Two years ago Dr Michael Michell and team at King’s College Hospital, London, set out to explore the benefits of tomosynthesis over conventional 2-D mammography. Their study has shown advantages in diagnostic accuracy and indicates that tomosynthesis could help to reduce the number of patient recalls for further examination and thus anxiety among women.
Films with vivid 3-D images draw millions to cinemas – regardless of the plot. This technology, which is based on a stereoscopic effect, is not only entertaining but also medically relevant, as demonstrated by the Amulet three-dimensional digital mammography system produced by Fujifilm.
Yes, it’s in beautiful Dresden again and -- as in 2006 when the city last hosted the Congress of the German Society for Senology -- this year’s Congress President is Professor Rüdiger Schulz-Wendtland (Department of Radiology, University of Erlangen). However, the repetition ends there; the congress topics will be anything but repeated. Report: Meike Lerner
No imaging modality is infallible -- not even mammography, the golden standard for early detection of breast cancer. Particularly in women with dense breast tissue, the diagnostic quality of conventional mammography frequently suffers in terms of sensitivity and specificity. However, the evolution of digital systems has produced technologies that optimise sensitivity as well as specificity and…
SECure TRAnsmission, the main aim of a spin-off from the Linköping Institute of Technology, was established in 1978. From this beginning, the Swedish firm Sectra has evolved into one of the world’s leading players in PACS and mammography solutions. Although secure communication systems remains a core business, the medical section has constantly grown since 1988, when Dr Torbjörn Kronander…
It’s digital mammography taken to the next level – or, so to speak, the next dimension as digital breast tomosynthesis (DBT) that provides high resolution 3-D imaging. For about two years this exciting technology has promised to become the magic bullet in the early detection of breast cancer, particularly in the dense breast.
How does a hospital decide what to do about in-house radiology if, for example, its consultant retires? Select a ‘new broom’ to brush out earlier practices, or make this an opportunity to redefine its radiology department’s services and objectives? In the latter case, outsourcing to receive diagnoses from an external radiologist might be potentially interesting. However, Dr Winfried…
It’s been around for decades, re-emerged in the ’90s and, today, experts see a bright future for tomosynthesis technology. Thus its progress and future developments, plus specialist uses (e.g. breast) will be a particular feature at the Radiological Society of North America scientific assembly and annual meeting in Chicago this year.
Digital breast tomosynthesis (DBT) is a promising new technology that acquires 3-D breast images. The individual images are presented as thin, high-resolution slices, which can be displayed individually or in a dynamic cine mode. Preliminary studies in a clinical setting have demonstrated that this new technology has the potential to improve not only the breast cancer detection but also to reduce…
Digital breast tomosynthesis (DBT) is a promising new technology that acquires 3-dimensional images of the breast. The individual images are presented as thin high-resolution slices that can be displayed individually or in a dynamic cine mode. Preliminary studies in a clinical setting have demonstrated that this new technology has the potential to improve not only the detection of breast cancers…
The Italian firm Internazionale Medico Scientifica (IMS) produces highly innovative mammography units under the brand name Giotto. More than 3,500 Giotto systems are now in use in 38 countries, mostly in Europe, America, China and the Far East. Reason enough for European Hospital to visit IMS in Pontecchio Marconi, Bologna.
The MVZ RNR Leverkusen Am Gesundheitspark (Germany), part of the RNR MVZ GmbH Association, is one of the most important breast diagnostics centres in the region, treating tens of thousands of patients annually. In line with this full capacity utilisation, the equipment at the practice is of the highest standard. Recently, tomosynthesis was installed, enabling the centre to offer patients the…
Siemens Healthcare was presenting its latest solutions for the early detection and treatment of breast cancer at the German Radiology Congress in Berlin. These Breast Care Solutions include a variety of imaging procedures, such as ultrasound, mammography, and magnetic resonance imaging (MRI), supplemented by IT and laboratory diagnostic solutions. Siemens places special focus on the third…
The overall success of MRI in diagnosing breast cancer and the exploding demand for breast MRI, in particular, have caused a scanner shortage in much of Europe. Dr Jean-Pierre Pruvo, Chairman of the French Society of Radiology, recently raised the alarm: ‘We have hundreds of thousands of women in France at risk for breast cancer, yet we do not have the means to provide a breast examination by…
The limitations of mammography are well documented, yet it is still the gold standard in breast cancer detection - particularly due to the positive cost-benefit ratio. Due to prohibitive costs, MRI exams are performed only in well-defined cases. The HIGHREX project (www.highrex.eu) aims to evaluate Single Shot Spectral Imaging (SSSI) technology for use in mamma diagnostics.
Sectra’s RIS/PACS enables workload sharing across multiple sites as well as handling of very large image stacks over strained networks. At this year’s ECR, the company is showing a range of products that further strengthen its cross-enterprise capabilities in radiology and mammography.
At ECR 2010 in Vienna, Sectra focus on solutions for increased productivity. Sectra RIS/PACS is a performance solution for wide area radiology. Built on the latest Sectra RapidConnectTM technology, it allows radiologists to work from any location that offers reasonable Internet access and to share images and information between multiple locations with ease.
In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers.
Digital mammography, which is considered the gold standard of breast imaging, has rendered image management and consequently the entire – purely on-screen – diagnostic process more reliable and more efficient.
Reducing dose and producing excellent image quality at the same time is the challenge of today´s mammography systems. The Institute for Clinical Radiology at the University Clinic Munich managed this challenge with the installation of two new digital full-field mammography solutions which in addition can be used for tomosynthesis. At June 25th, the clinic will demonstrate the benefits of these…
Every year the German Society for Senology congress facilitates interdisciplinary breast cancer discussion between gynaecologists, radiologists, surgeons, pathologists, internists, radio-oncologists and plastic surgeons. In an interview with Karoline Laarmann, of European Hospital, radiologist Professor Ingrid Schreer (right), head of the Breast Centre at the University Women's Hospital in Kiel,…
Delegates at the 2009 European Congress of Radiology (ECR) saw a series of presentations Friday unveiling new findings and key updates on digital breast tomosynthesis (DBT). As the body of research builds in this relatively unexplored field, the advantages and limitations of DBT compared with conventional full-field digital mammography (FFDM) and other modalities are becoming better defined.
The Dutch screening programme, which began in 1990, invites women aged 50-75 years for mammography screening every two years. Today, the national programme is undergoing considerable regional re-organisation. As one of a team of 12 radiologists at the Alkmaar Medical Centre, Dr Shirley Go is responsible for Mammography and Screening in a large Dutch region. Daniela Zimmermann, asked Dr Go about…
Early detection currently remains the most promising way to optimise the diagnosis and treatment of breast cancer, lower the mortality rate resulting from this disease, and improve patients' quality of life.
The diagnostic use of ultrasound has improved significantly because of improved resolution and reduction in artifacts, allowing increasingly more specific examination.
Although its standard description is simple: Photo detection at low light levels where single photon absorption events are counted, according to an internationally renowned medical imaging scientist, in terms of X-ray imaging, counting photons may really be the way to see the light.
The use of mammography to maintain breast health comes with a caveat: exposure of the breast to radiation, which can increase the susceptibility risk of breast cancer. Thus, using the lowest possible radiation dose for mammograms is of utmost importance.
The fact that the female breast is one of the most radiation sensitive organs in the human body is a major driver for all those searching for low radiation alternatives - one of these routes lies in photon counting.
In a pre-conference discussion with this year's President, Professor Hans-Heinrich Kreipe, Director of the Institute for Pathology at Hanover Medical School, he outlined the significance of MRI in breast cancer detection, and highlighted other topics for the event.
Dr Hiroyasu Yano reports on the effective use of tomosynthesis in orthopaedic surgery.
A promising mammography screening technology By Andrew Smith PhD, principal scientist at Hologic, Inc. in Bedford, Mass, is involved in research and development of digital imaging systems.
It is hoped that a new technology, digital breast tomosynthesis or 3-D mammography, will overcome three drawbacks of traditional screening mammography: discomfort with breast compression, cancer concealed within overlapping tissue and the limited number of views.
Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of scientific research and clinical application.
By Thomas Mertelmeier, Principal Scientist at Siemens AG Medical Solutions
What next? A combination of ultrasound and tomosynthesis? By Dr Ingvar Andersson
In 2002, Germany implemented an early detection programme for breast cancer. The digital Reference Centre For Mammography at the University Hospital Münster is one of five such centres in the country - and it's one of the most modern, providing digital systems for imaging and results evaluation as well as a mammo-PACS.
2D imaging - whether analogue or digital - is thought to miss detection of 20-30% of breast cancers. Early clinical results from studies using the new technology tomosynthesis indicate its potential to lower those percentages.
"Tomosynthesis is a hot topic in all the companies involved in mammography", Professor Danielsson pointed out. "But whereas they are developing more or less the same thing, Sectra has a totally different concept - photon-counting - a unique technology that, for the first time, processes X-rays one by one."
Shimadzu specialises in the production of advanced medical imaging systems and equipment, clinical diagnostic systems, including CT, digital subtraction angiography, cardiovascular systems, digital radiography & fluoroscopy systems, ultrasound and general radiography equipment.
From Mammography to Tomosynthesis - breast imaging is crucial in cancer screening and diagnosis. Keep up-to-date with research news, medical applications, and background information on breast imaging.
